Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (6208)	11/5/1998 2:41:00 PM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

11/05 06:11 Pfizer <PFE.N> says Viagra sales in Russia uncertain MOSCOW, Nov 5 (Reuters) - U.S. drug maker Pfizer Inc said on Thursday sales of its anti-impotency drug Viagra was uncertain in Russia due to the faltering economy. "Economic realities here are going to have a certain effect, but we hope that as word spreads sales will pick up," said Robert Marshall, head of Pfizer's Russian office. The drug was officially launched in Russia on Wednesday after a one month delay which Pfizer attributed to the effects of the economic crisis. Many banks saw their activities suspended leading to interruptions to imports of goods, including pharmaceuticals. About $1.0 million dollars worth of Viagra has now been imported into Russia, but Marshall said the economy was still too unstable to allow predictions on future sales. Some Russian medical professionals at a symposium on the drug's launch said Russian "muzhiki," or real men, may have trouble confessing to a need for the little blue pill, even if they can afford it. Pfizer officials said they were hoping to boost sales of the drug by getting it included on a list of vital medications that the government would pay for when prescribed to patients.